Navigation Links
Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2
Date:5/23/2013

gía de la compañía, y el impacto de los datos clínicos y otros datos técnicos. Las declaraciones prospectivas se basan en las actuales expectativas de la dirección y están sujetas a riesgos e incertidumbres que pueden causar que los resultados de Volcano difieran material y adversamente de las declaraciones contenidas aquí. Algunos de los posibles riesgos e incertidumbres que podrían causar que los resultados reales difieran incluyen el ritmo y extensión de la adopción de mercado de los productos y tecnologías de la compañía, resultados clínicos no esperados, incluyendo datos clínicos nuevos no esperados y análisis adicionales de datos clínicos existentes, acciones regulatorias no esperadas o retrasos o regulaciones gubernamentales, la capacidad de la compañía para mantener u obtener patentes o protección de la propiedad intelectual, competencia en general, presiones de la industria en general o de precios públicos, temas no previstos de fabricación, estrategias de crecimiento, la oportunidad y logro de hitos de desarrollo de productos, el resultado de litigios, el impacto y beneficios del desarrollo de mercado, introducciones de productos, nuevos datos no esperados, problemas de seguridad y técnicos, las condiciones del mercado y otros riesgos inherentes al desarrollo y comercialización de dispositivos médicos. Estos y otros riesgos e incertidumbres se describen totalmente en los archivos de Volcano presentados a la Comisión de Bolsa y Valores, incluyendo nuestro informe trimestral reciente en Formulario 10-Q. No debería depositarse una confianza indebida en las declaraciones prospectivas que se refieren solo a la fecha en que se realizaron. Volcano no asume obligación alguna de actualizar las declaraciones prospectivas para reflejar nueva información, eventos o circunstancias después de la fecha en que se r
'/>"/>
SOURCE Volcano Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Volcano Corporation Presentation At JMP Securities Conference To Be Webcast
2. Volcano to Highlight its Leadership in Precision Guided Therapy at EuroPCR 2012
3. Volcano Corporation Presentation At Jefferies Conference To Be Webcast
4. Volcano Corporation Presentation at Wells Fargo Conference to be Webcast
5. Volcano Corporation Schedules Second Quarter Conference Call, Webcast
6. Volcano Corporation Reports 13 Percent Growth In Second Quarter Revenues; FFR Disposable Revenues Increase 38 Percent
7. Volcano Corporation Presentation At Canaccord Genuity Conference To Be Webcast
8. FAME 2 Published in the New England Journal of Medicine, Volcano participates in the $84M NIH-Sponsored ISCHEMIA Trial
9. Volcano Corporation Presentation At Stifel Nicolaus Conference To Be Webcast
10. Volcano Announces Previous St. Jude Medical Products Infringe Volcano Patent and Jury Verdicts in Patent Trials with St. Jude Medical
11. Volcano Corporation Schedules Third Quarter Conference Call, Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... und BERKELEY, Kalifornien, und KOPENHAGEN, Dänemark, ... Biologics, Inc. , ein Weltmarktführer bei der ... gab heute bekannt, man werde im Rahmen ... Dänemark, um ca. 14.000 Liter Produktionskapazität erweitern. ... Kunden erhalten durch das innovative ...
(Date:5/21/2015)... May 21, 2015  BioClinica®, Inc., a leading ... announced it has partnered with Kinapse to accelerate ... using BioClinica,s Compass Intelligent Monitoring solution. ... a real difference in clinical research," BioClinica CEO ... this collaboration as it helps move the industry ...
(Date:5/21/2015)... May 21, 2015  Juniper Pharmaceuticals, Inc. (Nasdaq: ... focused on developing therapeutics that address unmet medical ... Frank Condella will present at the ... Thursday, June 4, 2015Time: , 1:00 PM EDTLocation: ... www.juniperpharma.com, under  ,Investor, or  click here ...
Breaking Medicine Technology:CMC Biologics erweitert GMP-Produktionskapazität in Europa 2CMC Biologics erweitert GMP-Produktionskapazität in Europa 3BioClinica and Kinapse Partner to Accelerate Risk-Based Monitoring Implementation 2BioClinica and Kinapse Partner to Accelerate Risk-Based Monitoring Implementation 3Juniper Pharmaceuticals to Present at Jefferies 2015 Global Healthcare Conference on June 4, 2015 2
... HASCO Medical, Inc. (OTCBB: HASC), ... in Alabama, Florida, and Mississippi, announced today that Mike Dumais ... and Mobility, a subsidiary of HASCO Medical Inc. ... at eLayaway.com, a business services, listing and alternative payments processor ...
... On July 9, 2011, Gamma Pharmaceuticals, Inc. (NASDAQ: GMPM.PK) ... (the "Meeting") as disclosed in the Company,s press release ... release invited shareholders to attend in person or by ... the Bellagio Resort, Las Vegas NV.  The agenda for ...
Cached Medicine Technology:HASCO Medical Inc. Names Mike Dumais the Vice President of Sales for Southern Medical and Mobility 2Gamma Pharmaceuticals, Inc. Holds Special Shareholders Meeting 2Gamma Pharmaceuticals, Inc. Holds Special Shareholders Meeting 3Gamma Pharmaceuticals, Inc. Holds Special Shareholders Meeting 4
(Date:5/21/2015)... 2015 Jhon Tamayo, founder and ... is excited to announce the launch of the ... for use exclusively in Tamayo's NY studio. What ... it's mathematically designed with symmetrical lines and shapes ... strains, commonly experienced by both beginner and experienced ...
(Date:5/21/2015)... Amercanex today announced that it ... fully electronic marketplace for industrial hemp and associated ... in which wholesale and retail distributors of hemp ... on a fully disclosed and transparent environment. , ... a unique blend of cutting-edge infrastructure, tools, and ...
(Date:5/21/2015)... NJ (PRWEB) May 21, 2015 ... communication consultancy to the pharmaceutical and biotechnology industries – ... during the 2015 BIO International Convention in Philadelphia, PA. ... Thinking Like a Payer,” will take place on ... Laurie Smaldone , PharmApprove President and CSO, will moderate ...
(Date:5/21/2015)... 2015 Neogenis Labs , a world ... has been named to the 2015 Austin A-List by the ... South by Southwest Interactive. , The A-List companies , ... 275 nominations, were officially revealed and named to the annual ... at ACL-Live. The 12 honorees for 2015 were named in ...
(Date:5/21/2015)... LOS ANGELES, CA (May 21, 2015) – BeMyDD ... today announced the launch of a new responsibility campaign to ... customers will receive $20 off their first ride by using ... grand prize of a “DD For a Year” (a $2000 ... the start of the summer season, also marks the beginning ...
Breaking Medicine News(10 mins):Health News:NY's Atmananda Yoga Studio Launches Its Patented "Alignment" Yoga Mat for Public Sale 2Health News:Amercanex is Revolutionizing Order and Efficiency in the Hemp Industry 2Health News:PharmApprove Panel at BIO Addresses Success in Drug Development Beyond Regulatory Approval 2Health News:PharmApprove Panel at BIO Addresses Success in Drug Development Beyond Regulatory Approval 3Health News:Neogenis® Labs Named to 2015 Austin A-List Most Promising Startups 2Health News:Neogenis® Labs Named to 2015 Austin A-List Most Promising Startups 3Health News:BeMyDD Announces Memorial Day Weekend Campaign to Decrease Drunk Driving Nationwide 2
... , TUESDAY, Jan. 4 (HealthDay News) -- Elderly people who ... researchers have found. The new study included more than ... examination and a psychiatric assessment. Compared with participants who still ... no teeth were much more likely to have experienced some ...
... HealthDay Reporter , TUESDAY, Jan. 4 (HealthDay News) -- A ... a test that could find even one stray cancer cell among ... The hope is that one day such a test, given soon ... working or not. It might even indicate beforehand which treatment would ...
... 4, 2010) With life expectancy increasing in Latin America, ... Results of an epidemiological study conducted by researchers ... on Aging (USDA HNRCA) at Tufts University and the ... a condition that increases a person,s risk of developing ...
... the possibility of autoimmunity and the indirect immunofluorescence ... blood test (ANA-HEp-2) used to detect ANA. However, ... occurs in up to 13% of healthy individuals. ... of autoantibodies that apparently are not associated with ...
... By Amanda Gardner HealthDay Reporter , MONDAY, Jan. ... of cancer on the left side of the colon, new ... the right side. The finding contradicts some previous research ... However, the right-side benefit shown in the new study, ...
... be linked to the development and severity of certain autoimmune ... Jan. 4 edition of the journal Chest . ... Interstitial Lung Disease Center at the University of Cincinnati and ... been found to affect the development of other autoimmune diseases, ...
Cached Medicine News:Health News:Scientists Aim for Test That Spots Single Cancer Cell in Blood Sample 2Health News:Scientists Aim for Test That Spots Single Cancer Cell in Blood Sample 3Health News:Vitamins C and E linked to metabolic syndrome in low-income Ecuadorians 2Health News:Vitamins C and E linked to metabolic syndrome in low-income Ecuadorians 3Health News:Accurate interpretation of antinuclear antibodies test key to confirming autoimmune disease 2Health News:Colonoscopies May Not Have 'Blind Spot' After All 2Health News:Colonoscopies May Not Have 'Blind Spot' After All 3Health News:Study shows vitamin D deficiencies may impact onset of autoimmune lung disease 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: